The varieties of psychedelic law
Neuropharmacology December 21, 2022 DOI: 10.1016/j.neuropharm.2022.109399 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Policy analysis Peer reviewed |
|---|---|
| Topics | Ayahuasca Psilocybin |
| Keywords | Controlled substance regulation Psychedelics policy reform Controlled substances legislation Therapeutic drug research Decriminalization initiatives Medical psychedelics |
| Citations | 59 |
| Key points | State and local psychedelic laws fall into five categories—decriminalization, supported adult use, medical use, clinical research, and policy analysis—and some jurisdictions create hybrid laws that blend elements of multiple categories. |
Abstract
After decades of prohibition, psychedelics are generating intense public and private interest. Scientists are researching the therapeutic properties of these substances, and mounting evidence supports their ability to treat a variety of mental health conditions. Meanwhile, dozens of cities and states are proposing or enacting psychedelics legislation to promote research, increase therapeutic and non-therapeutic access, and decrease criminal penalties associated with producing, possessing, or consuming psychedelics. This article is the first to produce a typology of state and local psychedelic laws, which fall into five general categories: decriminalization, supported adult use, medical use, clinical research, and policy analysis. The article defines each category and explains how some jurisdictions create hybrid psychedelic laws that blend elements of multiple categories. Following enactment, government agencies can shift laws from one category to another during the rulemaking process. This article is part of the Special Issue on "National Institutes of Health Psilocybin Research Speaker Series".
Citations in the library
Cited by 50
- Psychedelics: Threshold of a Therapeutic Revolution Neuropharmacology May 27, 2023
- Essentials of Informed Consent to Psychedelic Medicine JAMA Psychiatry April 10, 2024
- Psychedelic Medicine Exceptionalism. The American Journal of Bioethics 2025
- Psychedelics and workplace harm Frontiers in Psychiatry June 16, 2023
- Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges. CNS Drugs October 1, 2024
and 45 more in the library
Cites 8
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
- Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder JAMA Psychiatry August 24, 2022
- Global Street Food: la cocina de la calle Diseño interior 2009
- Harm potential of magic mushroom use: a review. Regulatory toxicology and pharmacology : RTP April 1, 2011
and 3 more in the library